FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York (Reuters) - Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men ...

For nearly a decade, Toni Matthews-El has published business topics ranging from cloud communication software to best steps for establishing your own LLC. In addition to Forbes Advisor, she's ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...

Johnson & Johnson last fall suffered a major legal defeat in its defense of antipsychotic Risperdal, but that loss was short-lived. After a jury ordered J&J to pay a plaintiff a staggering $8 billion, ...

Records from the Philadelphia County Court of Common Pleas reveal more than 3,000 new Risperdal lawsuits were filed in the first three months of 2017, driving up the total number of filings in this ...

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...

Johnson & Johnson's schizophrenia drug Risperdal at Skenderian Apothecary in Cambridge, Massachusetts, on Jan. 23, 2007. Photo: JB Reed/Bloomberg News. The Pennsylvania Supreme Court has ruled that ...